One-day vs five-day of octreotide infusion along with endoscopic therapy in the prevention of early rebleeding and mortality from esophageal varices: randomized control trial
Phase 4
Recruiting
- Conditions
- Cirrhosis with esophageal varices bleedingesophageal varices bleeding
- Registration Number
- TCTR20221004008
- Lead Sponsor
- Phramongkutklao Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 236
Inclusion Criteria
esophageal varices bleeding
cirrhosis
Age >20 years
Exclusion Criteria
Non-cirrhosis
Other source of bleeding
Concomitant GV
Failure to stop bleeding via endoscope
U/D: HCC, advanced malignancy, septic shock
Deny to participate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 5 day rebleeding 5 day rebleeding rate,6 weeks mortality 6 weeks mortality rate
- Secondary Outcome Measures
Name Time Method 6 weeks rebleeding 6 weeks rebleeding rate